Abstract
The present invention provides one or more immunogenic polypeptides for use in a preventive or therapeutic vaccine against latent or active infection in a human or animal caused by a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Furthermore a single or multi-phase vaccine comprising the one or more immunogenic polypeptides is provided for administration for the prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Additionally, nucleic acid vaccines, capable of in vivo expression of the multi-phase vaccine comprising the one or more immunogenic polypeptides, is provided for prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis.
Original language | English |
---|---|
IPC | A61K39/04 |
Patent number | WO2014114812 |
Filing date | 31/07/2014 |
Country | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 28/01/2013 |
Priority number | EP20130152908 |
Publication status | Published - 2014 |